Pharmaceutical Co-Crystals: Manufacturing, Bioavailability and Trends
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Physical Pharmacy and Formulation".
Deadline for manuscript submissions: 30 October 2024 | Viewed by 109
Special Issue Editors
Interests: pharmaceutical cocrystals; amorphous formulations; control of crystal size and habit
Special Issues, Collections and Topics in MDPI journals
Interests: crystal polymorphism; cocrystals; amorphous solid dispersions; nanocrystals; computational simulation of the solid state; artificial neural networks
Special Issues, Collections and Topics in MDPI journals
Interests: crystalline and amorphous pharmaceutical solid forms; poly(a)morphs; ball milling; solid-state characterization; crystal structure determination; X-ray diffraction; total scattering; molecular dynamics simulations
Special Issues, Collections and Topics in MDPI journals
Interests: thermal analysis; solid-state; drug design; physicochemical characterization; nanotechnology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are delighted to introduce our forthcoming Special Issue focused on "Pharmaceutical Co-crystals: Manufacturing, Bioavailability and Trends". In the dynamic landscape of pharmaceutical research, co-crystallization has emerged as a promising strategy to address several challenges related to traditional drug formulations.
This Special Issue aims to explore emerging approaches to the research and manufacturing of pharmaceutical co-crystals, including the latest developments in preparation, such as ball mill grinding (mechanochemistry) and solution-based methods. By combining active pharmaceutical ingredients (APIs) with co-formers, an improvement in the drug solubility, stability, and potentially bioavailability is expected. Exploring the impact of co-crystallization in drug bioavailability will therefore be key in the future development of drug delivery systems that incorporate this approach.
We invite you to join us as we navigate through the realms of manufacturing, bioavailability enhancement, and emerging trends in drug formulation.
Dr. Andrea Erxleben
Prof. Dr. Kyriakos Kachrimanis
Dr. André Luiz Carneiro S. Nascimento
Dr. Inês C. B. Martins
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- co-crystals
- manufacturing
- bioavailability
- pharmaceuticals
- drug delivery
- solid-state characterization
